Axcynsis Therapeutics
PrivateLast Round
VC Round
Oct 1, 2024
Total Funding Raised
$15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Axcynsis Therapeutics is a biotechnology company that develops antibody-drug conjugate (ADC) therapies designed for treating cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axcynsis Therapeutics Comparables
Compare Axcynsis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DotBio | 82% | |
| Albatroz Therapeutics | 79% | |
| Adcytherix | 78% | |
Axcynsis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 1, 2024 | ||||
| Seed | May 4, 2022 |
Axcynsis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Trinity Innovation Fund | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 188% MoM, reaching 916.
- Apr 21, 2025
Developing new Antibody Drug Conjugate (ADC) therapies.
Axcynsis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axcynsis Therapeutics's valuation, stock price, and market status.